Literature DB >> 19875996

Postabsorptive VLDL-TG fatty acid storage in adipose tissue in lean and obese women.

Birgitte Nellemann1, Lars C Gormsen, Jens S Christiansen, Michael D Jensen, Søren Nielsen.   

Abstract

Adipose tissue lipoprotein lipase (LPL) is a necessary enzyme for storage of very-low-density lipoprotein-triglyceride (VLDL-TG), but whether it is a rate-determining step is unknown. To test this hypothesis we included 10 upper-body obese (UBO), 11 lower-body obese (LBO), and 8 lean women. We infused ex vivo-labeled VLDL-(14)C-TG and then performed adipose tissue biopsies to understand the relationship between VLDL-TG storage and LPL activity in femoral and upper-body subcutaneous fat. Both fractional tracer storage and rate of storage of the VLDL-TG tracer were evaluated. VLDL-TG storage was also examined as a function of regional adipose tissue blood flow (ATBF), insulin, VLDL-TG turnover, regional fat mass, fat-free mass (FFM), and fat cell size. LPL activity per adipocyte was significantly greater in obese than lean women but not significantly different per gram lipid. Both VLDL-TG fractional tracer storage per kg lipid and VLDL-TG storage rate per kg lipid were similar in abdominal and femoral fat in all three groups and were not significantly different between groups. Multiple regression analysis identified FFM and femoral fat mass as significant independent predictors of VLDL-TG fractional tracer storage and insulin as a significant predictor of VLDL-TG fatty acid storage rate. LPL activity, ATBF, and VLDL-TG turnover did not predict VLDL-TG storage. We conclude that lower FFM and greater plasma insulin are associated with greater VLDL-TG deposition in abdominal subcutaneous and femoral fat. Greater femoral fat mass signals greater femoral VLDL-TG storage. We suggest that the differences in VLDL-TG storage in abdominal and femoral fat that occur with progressive obesity are regulated through mechanisms other than LPL activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19875996      PMCID: PMC2893248          DOI: 10.1038/oby.2009.370

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  31 in total

1.  Uptake of triglyceride fatty acids in adipose tissue in vivo in man.

Authors:  P Mårin; M Rebuffé-Scrive; P Björntorp
Journal:  Eur J Clin Invest       Date:  1990-04       Impact factor: 4.686

2.  Impact of body composition on very-low-density lipoprotein-triglycerides kinetics.

Authors:  Lars C Gormsen; Birgitte Nellemann; Lars P Sørensen; Michael D Jensen; Jens S Christiansen; Søren Nielsen
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-11-04       Impact factor: 4.310

3.  Fatty acid kinetic responses to exercise. Effects of obesity, body fat distribution, and energy-restricted diet.

Authors:  J A Kanaley; P E Cryer; M D Jensen
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

4.  Adipose tissue lipoprotein lipase (LPL) and triglyceride uptake in zucker rats.

Authors:  C A Maggio; M R Greenwood
Journal:  Physiol Behav       Date:  1982-12

5.  The effects of weight loss on the activity and expression of adipose-tissue lipoprotein lipase in very obese humans.

Authors:  P A Kern; J M Ong; B Saffari; J Carty
Journal:  N Engl J Med       Date:  1990-04-12       Impact factor: 91.245

6.  A micromethod for assay of lipoprotein lipase activity in needle biopsy samples of human adipose tissue and skeletal muscle.

Authors:  M R Taskinen; E A Nikkilä; J K Huttunen; H Hilden
Journal:  Clin Chim Acta       Date:  1980-05-21       Impact factor: 3.786

7.  Influence of body fat distribution on free fatty acid metabolism in obesity.

Authors:  M D Jensen; M W Haymond; R A Rizza; P E Cryer; J M Miles
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

Review 8.  Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases.

Authors:  R H Eckel
Journal:  N Engl J Med       Date:  1989-04-20       Impact factor: 91.245

9.  Lipoprotein lipase: size of the functional unit determined by radiation inactivation.

Authors:  A S Garfinkel; E S Kempner; O Ben-Zeev; J Nikazy; S J James; M C Schotz
Journal:  J Lipid Res       Date:  1983-06       Impact factor: 5.922

10.  Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution.

Authors:  M Krotkiewski; P Björntorp; L Sjöström; U Smith
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

View more
  6 in total

1.  Meal fat storage in subcutaneous adipose tissue: comparison of pioglitazone and glipizide treatment of type 2 diabetes.

Authors:  Ananda Basu; Rita Basu; Vishwanath Pattan; Robert A Rizza; Michael D Jensen
Journal:  Obesity (Silver Spring)       Date:  2010-06-10       Impact factor: 5.002

2.  Short-term regional meal fat storage in nonobese humans is not a predictor of long-term regional fat gain.

Authors:  Susanne B Votruba; Michael D Jensen
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-14       Impact factor: 4.310

3.  Similar VLDL-TG storage in visceral and subcutaneous fat in obese and lean women.

Authors:  Esben Søndergaard; Birgitte Nellemann; Lars P Sørensen; Lars C Gormsen; Jens S Christiansen; Erik Ernst; Margit Dueholm; Søren Nielsen
Journal:  Diabetes       Date:  2011-09-12       Impact factor: 9.461

4.  Femoral adipose tissue may accumulate the fat that has been recycled as VLDL and nonesterified fatty acids.

Authors:  Siobhán E McQuaid; Sandy M Humphreys; Leanne Hodson; Barbara A Fielding; Fredrik Karpe; Keith N Frayn
Journal:  Diabetes       Date:  2010-08-03       Impact factor: 9.461

5.  Visceral fat does not contribute to metabolic disease in lipodystrophy.

Authors:  N Malandrino; J C Reynolds; R J Brychta; K Y Chen; S Auh; A M Gharib; M Startzell; E K Cochran; R J Brown
Journal:  Obes Sci Pract       Date:  2019-01-24

6.  Fat Cell Size: Measurement Methods, Pathophysiological Origins, and Relationships With Metabolic Dysregulations.

Authors:  Run Zhou Ye; Gabriel Richard; Nicolas Gévry; André Tchernof; André C Carpentier
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.